相关实验视频
Updated: May 12, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
怀孕期间吃饭的时间和血糖控制:系统性审查
Hedda L Boege1, Curie Park1, Robin Gagnier1
1School of Global Public Health, New York University, New York, NY, USA.
概括
饮食时间会影响怀孕期间的血糖控制. 晚餐和更短的夜间禁食与较差的血糖管理相关,无论妊娠糖尿病状况如何.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 代谢健康 代谢健康
- 临床营养学 临床营养学
背景情况:
- 怀孕期间的血糖失调带来了不良分娩结果和未来母亲慢性疾病的风险.
- 饮食时间影响血糖控制,但其在怀孕中的作用需要进一步调查.
- 现有的研究缺乏全面的了解,即饮食时间如何影响妊娠期间的血糖参数.
研究的目的:
- 系统地审查有关孕妇饮食时间和血糖结果之间的相关性现有的文献.
- 综合从干预和观察性研究中关于怀孕期间饮食时间和血糖控制的证据.
- 确定进食时间对孕妇血糖管理的潜在影响.
主要方法:
- 在PubMed,CINAHL,EMBASE和Web of Science进行了系统的文献搜索,寻找2024年3月之前发表的研究.
- 该审查遵循了系统审查和元分析 (PRISMA) 准则的首选报告项目,并与PROSPERO (CRD42024574992) 注册.
- 在评估了1804篇文章后,包括了14项符合条件的研究 (5项干预研究,8项观察研究),重点是量化数据,将饮食时间与妊娠糖尿病 (GDM) 或没有妊娠糖尿病 (GDM) 的孕妇的血糖结果联系起来.
主要成果:
- 摄入食物的时间与孕妇的血糖结果有显著的相关性,无论她们的妊娠糖尿病 (GDM) 状态如何.
- 晚餐时间和更短的夜间禁食持续时间始终与较差的血糖控制有关.
- 这些发现强调了个体吃什么和怀孕期间血糖调节之间的直接关系.
结论:
- 饮食时间是影响怀孕期间血糖控制的独立因素.
- 晚些时候的饮食模式和减少的夜间禁食期间与不良的血糖结果有关.
- 将时间考虑纳入饮食建议可以提高孕妇的血糖管理策略.
更多相关视频
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
813
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
813
Hypoglycemia and Glucagon
142
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
142
Oral Hypoglycemic Agents: Glinides
111
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
111
Oral Hypoglycemic Agents: Biguanides and Glitazones
140
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
140
Hormonal Regulation
43.0K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.0K

